Lin, Neng-Yu
Chen, Syue-Ting
Chang, Hsiu-Ling
Lu, Meng-Yao
Yang, Yung-Li
Chou, Shu-Wei
Lin, Dong-Tsamn
Lin, Kai-Hsin
Jou, Shiann-Tarng
Hsu, Wen-Ming
Huang, Min-Chuan http://orcid.org/0000-0002-0704-3447
Chang, Hsiu-Hao http://orcid.org/0000-0003-1832-8509
Funding for this research was provided by:
Ministry of Science and Technology, Taiwan (108-2314-B-002-154, 109-2314-B-002-129, 110-2314-B-002-088-MY3, 109-2320-B-002-039, 108-2320-B-002 -064 -MY3)
National Taiwan University Hospital (111-S0028, 108C101-83, 109C101-93, NSCCMOH-94-8, NSCCMOH-131-92)
Article History
Received: 23 October 2021
Revised: 29 January 2022
Accepted: 2 February 2022
First Online: 15 February 2022
Competing interests
: The authors declare no competing interests.
: Regarding the use of human neuroblastoma tumor samples, written informed consent was obtained from all patients and this study was approved by the Institutional Review Board of the National Taiwan University Hospital (IRB No: 201812005RIND). All mouse experiments were carried out in accordance with a study protocol approved by the National Taiwan University College of Medicine and College of Public Health Institutional Animal Care and Use Committee (IACUC) (No. 20180305).